Literature DB >> 312874

The effect of nucleosides and deoxycoformycin on adenosine and deoxyadenosine inhibition of human lymphocyte activation.

J Uberti, J J Lightbody, R M Johnson.   

Abstract

Micromolar deoxyadenosine inhibits leucine uptake during the 1st day of proliferation in mitogen-stimulated lymphocytes if adenosine deaminase is inhibited. This inhibition occurs before DNA synthesis begins, suggesting that deoxyadenosine can affect mitogenesis by mechanisms that do not involve ribonucleotide reductase inhibition. If deoxyadenosine addition to mitogen-stimulated lymphocytes is delayed to the 2nd or 3rd day post-stimulation, inhibition of proliferation is markedly reduced. Although the time dependence of deoxyadenosine toxicity resembles that of adenosine, these compounds appear to inhibit early protein synthesis by different mechanisms: 1) deoxycoformycin markedly potentiates deoxyadenosine but not adenosine; 2) deoxycytidine and thymidine reverse deoxyadenosine toxicity but do not alter adenosine toxicity.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 312874

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  14 in total

1.  Purinogenic lymphocytotoxicity: clues to a wider chemotherapeutic potential for the adenosine deaminase inhibitors.

Authors:  R F Kefford; R M Fox
Journal:  Cancer Chemother Pharmacol       Date:  1983       Impact factor: 3.333

2.  S-Adenosylhomocysteine hydrolase activity in a lymphoblastoid cell line from a patient with adenosine deaminase dificiency disease.

Authors:  S Tsuchiya; S Nakae; T Konno; K Tada
Journal:  J Inherit Metab Dis       Date:  1981       Impact factor: 4.982

Review 3.  Adenosine deaminase inhibitors: their role in chemotherapy and immunosuppression.

Authors:  R I Glazer
Journal:  Cancer Chemother Pharmacol       Date:  1980       Impact factor: 3.333

Review 4.  Metabolic defects in immunodeficiency diseases.

Authors:  A D Webster
Journal:  Clin Exp Immunol       Date:  1982-07       Impact factor: 4.330

5.  Effects of deoxyadenosine on the activation of ADA inhibited T & B cells.

Authors:  A D Webster; H Ip; S Pereira
Journal:  Clin Exp Immunol       Date:  1982-12       Impact factor: 4.330

6.  Resistance of an adenosine kinase-deficient human lymphoblastoid cell line to effects of deoxyadenosine on growth, S-adenosylhomocysteine hydrolase inactivation, and dATP accumulation.

Authors:  M S Hershfield; N M Kredich
Journal:  Proc Natl Acad Sci U S A       Date:  1980-07       Impact factor: 11.205

7.  Action of deoxycoformycin on human T cell colonies in vitro.

Authors:  N R Colledge; A S Krajewski; J F Smyth; A H Wyllie
Journal:  Clin Exp Immunol       Date:  1982-10       Impact factor: 4.330

8.  Resistance of pokeweed mitogen-stimulated B cells to inhibition by deoxyadenosine.

Authors:  A R Hayward
Journal:  Clin Exp Immunol       Date:  1980-07       Impact factor: 4.330

9.  Regulation of ribonucleotide reductase activity in mammalian cells.

Authors:  J G Cory; A Sato
Journal:  Mol Cell Biochem       Date:  1983       Impact factor: 3.396

10.  Possible metabolic basis for the different immunodeficient states associated with genetic deficiencies of adenosine deaminase and purine nucleoside phosphorylase.

Authors:  D A Carson; D B Wasson; E Lakow; N Kamatani
Journal:  Proc Natl Acad Sci U S A       Date:  1982-06       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.